ECTS 2016


About Menu
  • amgen
  • gold
  • AgNovos
  • Alexion
  • MSD
  • silver
  • Lilly
  • UCB
  • Ultragenyx
  • bronze
  • Nature Reviews

Menu Programme Exhibition

Extra Menu

Back Menu

The following services will require a network connection...


Back Menu

Scientific Programme


    Back Menu

    Programme Day Name


      Back Menu

      Programme Day Name


        Back Menu

        Programme Day Name


          Back Menu

          Programme Day Name


            Back Menu

            Programme Day Name


              Back Menu

              Posters (full list)

              Poster Categories

              Back Menu

              Poster categories


              Back Menu

              Posters by category

              Poster authors

              Back Menu

              Poster authors


              Back Menu


              Speakers Sessions

              Back Menu

              Speaker name


                Back Menu

                Author affiliations


                Back Menu

                Floorplan viewer

                'Pinch' to zoom

                'Drag' to move the floorplan around

                Double click/tap to zoom

                Use scroll wheels to zoom in/out

                Use the +/- to zoom in and out on non-touch devices

                Hint: In landscape view on touch devices, scroll the page by moving finger up and down at the far right/left of the page


                Back Menu


                Back Menu


                Back Menu


                Back Menu

                ECTS2016 - AgNovos (Stand 20)

                AgNovos Healthcare is a privately-funded medical device company dedicated to developing innovative treatments for bone health diseases and other therapeutic categories. AgNovos’ global headquarters is in the United States near Washington, D.C. Its European headquarters is in Zurich, Switzerland.  The Company was founded in 2012 by renowned orthopedic surgeon Dr. James Howe.  Through scientific rigor and the compassion born of Dr. Howe’s decades of working with patients, AgNovos aims to reduce the devastating personal and societal costs of diseases like osteoporosis. The company is developing innovative treatments that have the potential to alter the landscape of bone health. By bringing new technology to market, the company strives to help patients maintain their mobility and independence.



                Back Menu

                ECTS2016 - Alexion (Stand 4)

                Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed and commercializes Soliris® (eculizumab), the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), two life-threatening ultra-rare disorders. As the global leader in complement inhibition, Alexion is strengthening and broadening its portfolio of complement inhibitors, including evaluating potential indications for eculizumab in additional severe and ultra-rare disorders. Alexion’s metabolic franchise includes two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare disorders, Strensiq® (asfotase alfa) to treat patients with hypophosphatasia (HPP) and Kanuma™ (sebelipase alfa) to treat patients with lysosomal acid lipase deficiency (LAL-D). In addition, Alexion is advancing the most robust rare disease pipeline in the biotech industry, with highly innovative product candidates in multiple therapeutic areas.



                Back Menu
                ECTS2016 - Alexion (Stand 5)


                Back Menu
                ECTS2016 - Alexion (Stand 6)


                Back Menu

                ECTS2016 - Bruker (Stand 12)

                Bruker MicroCT develops and manufactures micro and nano-CT scanners both in vivo and ex vivo with high resolution and imaging performance. We also provide a comprehensive software suite for 3D analysis and visualization. Our company was founded in 1996 as “SkyScan” and joined the Bruker family of leading imaging and analytical equipment suppliers in 2012.

                Bruker microCT is a trusted solution provider in bone research, attested by hundreds of publications in fields such as osteoporosis, arthritis, orthopedics and dental specialties. More widely we equip researchers throughout life science fields with 3D imaging solutions for both calcified and non-calcified tissues, including multi-modality solutions merging microCT with bioluminescence, fluorescence, PET and SPECT. Our broad product line is founded on three decades at the leading edge of micro-tomography research. Scanners are supplied with comprehensive advanced 3D analysis software featuring high speed GPU reconstruction, versatile volume of interest selection and segmentation tools, measurement of a long list of 3d and 2d parameters and customizable batch operations. In-depth bone research and morphometric support is provided. Bruker-MicroCT customers are closely supported by the global distributors; please visit for more information.



                Back Menu

                ECTS2016 - Bruno (Stand 19)

                Bruno Farmaceutici SpA is a fast-growing Italian pharmaceutical company focused on researching, developing and offering the market advanced therapeutic solutions and improved formulations.Since a long time Bruno is the Italian market leader in the solid oral corticosteroid segment and in the Metformin market for Type-2 diabetes.

                In the recent years Bruno has evolved into a more complete and mature company, developing advanced and improved formulations of Alendronate, Flecainide and Ciprofloxacin for otologic use.

                Also a new breakthrough technology in the Ophtalmic market for the dry-eye syndrome has been developed and launched internationally in the last two years.

                Still based in Italy with a strong focus on the internal market, Bruno ha salso started expanding abroad with the final purpose of making available its products in several markets throughout Europe.



                Back Menu

                ECTS2016 - CeGaT (Stand 21)

                As a human genetic diagnostics provider we offer the decoding of genetic information and its medical interpretation. In 2010 we became the first company to establish high-throughput sequencing in human genetic diagnostics. Using this technology it is possible to analyze many regions of the genome simultaneously.

                For our Diagnostic Panels we use state of the art next-generation sequencing (NGS) technology to simultaneously analyze all known genes associated with a certain disease. This approach is much faster and cheaper than conventional methods.

                In addition to Diagnostic Panels we also offer Tumor Diagnostics, Exome Diagnostics and Single Gene Testing.



                Back Menu

                ECTS2016 - ECTS (Stand 14)

                The ECTS is the major organisation in Europe for researchers and clinicians working in the field of calcified tissues and related fields. For over 50 years the Society has acted as a forum to promote the highest levels of knowledge, research and education through its annual meetings, training courses and grants and awards. Membership of the ECTS is open to anyone working in the field at whatever stage in their career. Come and meet us in Rome at Stand number 14/15.



                Back Menu
                ECTS2016 - ECTS (Stand 15)


                Back Menu

                ECTS2016 - Faxitron (Stand 7)

                As the world’s only fully vertically integrated and dedicated cabinet X-ray company, Faxitron is the industry standard. Faxitron systems offer compact, fully-shielded digital imaging and pre-clinical DEXA systems with the highest resolution (up to 100 lp/mm) and the largest field of view in the market.

                Ultra-high resolution X-ray imaging is an important tool in investigating a variety of disease states. From metastatic cancer to arthritis and osteoporosis, small animal models are commonly used. Both in vivo and ex vivo planar imaging is used to screen, track, and evaluate structural changes in these studies. Cabinet X-ray systems allow researchers to take images directly in the vivarium to protect the integrity of the colony. These planar imaging systems are less expensive, subject animals to lower doses, and provide faster results than microCT systems.

                Faxitron cabinets can be placed directly on the bench top in the lab, or wherever easy access to imaging is needed, no additional shielding is required. Multiple cabinet and detector sizes with microfocus sources, up to 100kV, make our systems ideal for the full range of small animal in vivo and ex vivo imaging. As the pioneer in cabinet X-ray, Faxitron has defined the market by developing X-ray sensor technology and innovative systems to meet the evolving needs of our customers.


                German Diagnostic Society

                Back Menu
                ECTS2016 - German Diagnostic Society (Stand 16)

                Mindways CT

                Back Menu

                ECTS2016 - Mindways CT (Stand 24)

                MindwaysCT is an industry leader and technology innovator, providing physicians with systems that enable the fully quantitative assessment of CT images. Mindways continues research and development efforts to advance quantitative CT (QCT) technologies for new and innovative applications.

                MindwaysCT premier product, QCT Pro™ is the market leader in quantitative CT bone mineral density analysis. QCT Pro™ is uniquely designed to guide the user through an intuitive workflow to quickly and efficiently produce BMD patient reports. QCT Pro™ hip BMD measurements are interpreted in the same manner as DXA measurements, while volumetric spine measurements provide exceptional sensitivity to short-term bone density change.

                MindwaysCT Asynchronous QCT Pro is the next generation of QCT: a patient phantom is not required during the scan. Monthly phantom scans are used to calibrate patient scans independently of the patient. Asynchronous QCT further simplifies workflow, and it facilitates opportunistic, dual-use and retrospective BMD measurement from CT scans. Asynchronous QCT allows a spine and/or hip BMD measurement to be extracted from non-IV contrast CT scans done for other indications, including abdomen/pelvis/spine CT, CT colonography, CT urography, LDCT, cancer related PET CT, among others. More than 24 million such CT scans are done annually in the U.S. and most of these are in an at-risk patient population. This presents an opportunity to greatly increase osteoporosis screening with no additional radiation dose to the patient. PACS archives can be used to obtain BMD estimates on CT scans done days, weeks or years ago. Associations between BMD and clinical outcomes can be obtained. Patients with previously unappreciated low bone mass that might benefit from a follow-up BMD study are identified. Asynchronous QCT is a cost-effective bone-health program whether it is used as a standalone screening program or as a tool for identifying patients, that might benefit from specialty bone-health services.



                Back Menu

                ECTS2016 - MSD (Stand 25)

                Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit and connect with us on Twitter, Facebook and YouTube.

                MSD, Kenilworth, NJ 07033. USA  



                Back Menu
                ECTS2016 - MSD (Stand 26)

                SCANCO Medical AG

                Back Menu

                ECTS2016 - SCANCO Medical AG (Stand 10)

                Industry-Leading Provider of microCT (micro-computed tomography) Systems and Solutions.

                SCANCO Medical has been a pioneer in the field of high-resolution computed tomography for more than two decades. Starting with the first installation in Switzerland in 1988 we now have systems for medical and industrial applications operating on six continents.

                We offer a wide range of microCT scanners for specimen and preclinical as well as clinical use. These systems are supplied with high-end computing equipment and sophisticated analysis and visualization software to provide the most comprehensive and industry-leading imaging solutions.

                SCANCO Medical also offers scanning, analysis and consulting services for a wide range of applications.


                Stratec Medizintechnik GmbH

                Back Menu

                ECTS2016 - Stratec Medizintechnik GmbH (Stand 23)

                Stratec Medizintechnik is the world´s most successful producer of pQCT-based bone densitometry scanners for clinical and preclinical applications. These systems offer more than conventional 2-dimensional bone densitometry. Results are presented in real density units (g/cm³) . Unlike in 2-dimensional absorptiometric machines pQCT derived density measures are independent of bone size. Therefore pQCT can be applied to all age groups and body sizes. Additionally geometical properties of bone can be analysed which enables the user to estimate noninvasively bone´s mechanical proper ties. The combined analysis of muscle and bone parameters allows a detailed diagnosis and the differentiation of disuse osteopenia from true osteoporosis.

                The sister company Novotec Medical is manufacturer of Galileo vibration training devices for muscle stimulation and of Leonardo motion analysis systems (mechanography) . Due to the side alternating technology a natural movement similar to human gait is employed. Improvement of muscle force and power, treatment of back pain and abatement of immobility are typical fields of application. Short training times and fast success make it an ideal tool for corporate health care.

                For more than 25 years the consolidated companies collaborate closely with international research facilities. The realised results are continuously incorporated in our products.

                pQCT bone density and geometry, Leonardo mechanography and Galileo training are building blocks of a holistic concept for diagnosis and therapy of musculoskeletal disorders.

                The portfolio of imaging, mot ion analysis and Galileo t raining adds up to a holisticconcept around the issue of muscle and bone, ranging from diagnosis to treatment. Novotec Medical is project partner of ESA ( European Space Agency) in several projects e.g. for the evaluation of efficient t raining measures to avoid muscle and bone loss during space missions and collaborates worldwide with other renowned research facilities like Charite´ Berlin, university clinic Cologne and ETH Zuerich.


                Back Menu

                ECTS2016 - Ultragenyx (Stand 1)

                Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Ultragenyx formed a collaboration with Kyowa Hakko Kirin Co., Ltd. (KHK) to jointly develop and commercialize KRN23 for the treatment of XLH. KRN23 is a fully human monoclonal antibody administered via subcutaneous injection that is designed to bind and thereby reduce the excessive biological activity of FGF23.

                Multiple clinical studies of KRN23 in adult patients with XLH have been completed and Ultragenyx and Kyowa Hakko Kirin intend to continue development of KRN23 in adults with XLH. In addition, a Phase 2 study in pediatric patients with XLH is ongoing.

                Kyowa Hakko Kirin is a leading biopharmaceutical company in Japan focusing on its core business area of oncology, nephrology, and immunology/allergy. Kyowa Hakko Kirin leverages antibody-related leading-edge technologies to discover and develop innovative new drugs aiming to become a global specialty pharmaceutical company which contributes to the health and well-being of people around the world.

                For more information, please visit or


                Back Menu
                ECTS2016 - Ultragenyx (Stand 2)


                Back Menu
                ECTS2016 - Ultragenyx (Stand 3)


                Back Menu

                ECTS2016 - About

                We are delighted to provide you with details of the 43rd Meeting of the European Calcified Tissue Society (ECTS) which will take place in Rome, Italy.

                Recognised as the foremost annual European gathering in the field, ECTS 2016 will feature a broad and stimulating scientific programme addressing the very latest advances, challenges, and controversies in bone and calcified tissues.

                With an international delegation of scientists, clinicians and researchers in attendance, including many of the sector's leading lights, the Congress will be a unique opportunity to share in the vision of leading experts and discover what the future holds for this fast moving and exciting sector of medical research and practice.

                In 2016 the Congress will be heading to the beautiful city of Rome, fast becoming a renowned centre of medical innovation and research.  Boasting a vibrant scientific community, Rome is set to provide the perfect setting for four exciting days of innovation, discovery and education from across the bone and calcified tissue field.

                We are pleased to welcome you to the stunning city of Rome in 2016!

                Prof. Claus-C. Glüer (ECTS President & SPC Chair)

                Prof. Anna Teti (LOC Chair)

                The European Calcified Tissue Society

                Welcome to your society.

                Our mission is to promote excellence in research into the field of calcified tissues within Europe, and to ensure the findings are disseminated to enable benefit to patients with metabolic bone disease.

                Aims of the ECTS

                To advance scientific knowledge of the structure and function of calcified tissues and related subjects. To promote basic and clinical research in this field and to publish and disseminate the results of such research. To foster a multidisciplinary approach and to stimulate, through meetings, symposia, study groups, lectures, seminars and other means, exchange of information and collaboration. To act as an authoritative body for the purpose of consultation in matters of public and professional interest concerning research in calcified tissues and related subjects in Europe. For more information about becoming a member of the European Society of Calcified Tissue, see or call our membership team on +44 (0)1454 642245

                We look forward to working with you.


                ‚Äč2016 Committees

                Scientific Programme Committee

                Chair: Claus-C. Glüer (Kiel, Germany)

                Bente Langdahl (Aarhus, Denmark) - SPC 2016 Co-Chair
                Richard Eastell (Sheffield, UK) - Clinical Co-Chair
                Hans van Leeuwen (Rotterdam, Netherlands) - Pre-Clinical Co-Chair
                Martina Rauner (Dresden, Germany) - New Investigator Co-Chair
                Anna Teti (L'Aquila, Italy) - LOC Chair

                Tim Arnett (London, UK)
                Stuart Ralston (Edinburgh, UK)
                Lorenz Hofbauer (Dresden, Germany)
                Hans van Leeuwen (Rotterdam, Netherlands)
                Martine Cohen-Solal (Paris, France)
                Gudrun Stenbeck (London, UK)
                Miep Helfrich (Aberdeen, UK)
                Franz Jakob (Wuerzburg, Germany)
                Erik Fink Eriksen (Oslo, Norway)

                Local Organisation Committee

                Chair: Anna Teti (L'Aquila, Italy)

                Stefano Schiaffino (Rome, Italy)
                Maria Luisa Bianchi (Milan, Italy)
                Salvatore Minisola (Milan, Italy)
                Nadia Rucci (L'Aquila, Italy)
                Riccardo Paone (L'Aquila, Italy)
                Mattia Capulli (L'Aquila, Italy)

                Scientific Advisors
                Adolfo Díez Pérez (Barcelona, Spain)
                Agi Grigoriadis (London, UK)
                André Uitterlinden (Rotterdam, Netherlands)
                Andrea del Fattore (L'Aquila, Italy)
                Anna Teti (L,Aquila, Italy)
                Anne de Pape (MSD, USA)
                Annesofie Lunde Jensen (Aarhus, Denmark)
                Aymen Idris (Edinburgh, UK)
                Bente Langdahl (Aarhus, Denmark)
                Bram Perdu (Antwerp, Belgium)
                Brendan Boyce (Rochester, USA)
                Cesar Libanati (Amgen, USA)
                Claus Glüer (Kiel, Germany)
                Cyrus Cooper (Oxford, UK)
                Davide Ruffoni (Zurich, Switzerland)
                Emma Duncan (Brisbane, Australia)
                Eric Hesse (Hamburg, Germany)
                Erik Fink Eriksen (Oslo, Norway)
                Frank de Vries (Utrecht, The Netherlands)
                Hank Kronenberg (Boston, USA)
                Hans van Leeuwen (Rotterdam, The Netherlands)
                Henry Bryant (Eli Lilly USA)
                Ian Reid (Auckland, New Zealand)
                Jane Lian (Worcester, USA)
                Joanna Price (Bristol, UK)
                Karl Michaëlsson (Uppsala, Sweden)
                Keith Hruska (Washington, USA)
                Kristina Åkesson (Malmo, Sweden)
                Margaret Paggiosi (Sheffield, UK)
                Maria Luisa Bianchi (Milan, Italy)
                Marie-Helene Lafage-Proust (Saint Etienne, France)
                Martina Rauner (Dresden, Germany)
                Mary Bouxsein (Boston, USA)
                Masaki Noda (Tokyo, Japan)
                Michael Amling (Hamburg, Germany)
                Michael Kniessel (Basel, Switzerland)
                Miep Helfrich (Aberdeen, UK)
                Moustapha Kassem (Odense, Denmark)
                Natalie Sims (Melbourne, Australia)
                Östen Ljunggren (Uppsala, Sweden)
                Peter Croucher (Sydney, Australia)
                Pierre Marie (Paris, France)
                Ralph Müller (Zurich, Switzerland)
                Richard Eastell (Sheffield, UK)
                Riku Kiviranta (Turku, Finland)
                Shigeaki Kato (Tokyo, Japan)
                Steven Cummings (San Francisco, USA)
                Stuart Ralston (Edinburgh, UK)
                Sundeep Khosla (Rochester, USA)
                Theresa Guise (Indiana, USA)
                Thomas Clemens (Baltimore, USA)
                Tim Arnett (London, UK)
                Toshio Matsumoto (Tokushima, Japan)
                Ulf Lerner (Umea, Sweden)
                Uwe Kornak (Berlin, Germany)
                Willem Lems (Paris, France)


                Back Menu

                ECTS2016 - Contact

                European Calcified Tissue Society (ECTS)



                Congress secretariat


                Euro House,

                22 Apex Court,


                Bradley Stoke,

                Bristol BS32 4JT


                Tel: +44 (0) 1454 642240

                Fax: +44 (0) 1454 642222




                Back Menu

                ECTS2016 - Personal Planner.

                Please follow the link to be directed to the Personal Planner.

                Personal Planner


                Back Menu

                ECTS2016 - General

                The ECTS 2016 congress is being held at the Palazzo dei Congressi.

                Palazzo dei Congressi
                Piazza John Fitzgerald
                Kennedy, 1
                Roma, Italy

                Tel: 0039 06 5451 3710

                ECTS 2016 Main Entrance address – Piazzale Kennedy

                Public Transport:
                If you would like to travel to the congress by Metro, the Palazzo dei Congressi is conveniently surrounded by 4 Metro stations: EUR Magliana, EUR Palasport, Eur Femi and Laurentina.  Each of these stations is serviced by Metro Line B.  Of the 4 stations, EUR Femi is the closest to the Palazzo dei Congressi.

                The closest Metro station to the Sheraton Roma is the the EUR Magliana, use Metro Line B to reach this station.

                Time Zone: Rome operates under Central European Time (CET).

                Language: The local language is Italian.

                Visa and Passport Requirements: Visa and passport requirements vary depending on which country you are departing from. It is advised to  check the travel guidelines of your own consulate.

                Currency: The currency in Italy is the EURO.

                ECTS goes Green:
                The ECTS are aware of the environmental impact of holding a large congress, and we are working closely with our suppliers and staff to ensure that environmentally friendly policies are in place.

                NI Network

                Back Menu

                ECTS2016 - NI Network

                New Investigator Programme

                NI Sessions

                The ECTS New Investigator Committee have organised a special programme specifically designed for New Investigators. This includes a special seminar and networking event and workshops that will take place across the meeting.


                To facilitate networking
                Enhance the exposure of data presented by New Investigators
                Provide a space to improve essential skills in a safe environment
                Enable greater exchange with mentors and senior investigators
                Foster methodological exchange between New Investigators

                Target audience

                Bachelor, Masters and PhD students
                Early independent researchers (within 2 years of becoming independent)

                New Investigator Seminar & Gathering

                Sunday 15 May 2015 18:45–21:00

                The main event will be our New Investigator series of oral poster presentations. Delegates will hear the latest research from our 9 selected New Investigator abstract authors, and the two best presentations, as decided by the audience, will be awarded our newly created Best Poster prizes. The evening will end with a networking reception, drinks and buffet dinner, with further opportunities for discussion of our New Investigators' research.

                New Investigator Lounge

                Take a break, enjoy refreshments, and network with your peers in the New Investigator Networking Lounge.

                Make the time to visit this busy hub right at the centre of the exhibition, where you can meet, connect and relax with associates and make new friends.


                Back Menu
                ECTS2016 - Social


                Back Menu

                ECTS2016 - Venue

                The ECTS 2016 congress is being held at the Palazzo dei Congressi.

                Palazzo dei Congressi
                Piazza John Fitzgerald
                Kennedy, 1
                Roma, Italy

                Tel: 0039 06 5451 3710

                ECTS 2016 Main Entrance address – Piazzale Kennedy

                Public Transport:
                If you would like to travel to the congress by Metro, the Palazzo dei Congressi is conveniently surrounded by 4 Metro stations: EUR Magliana, EUR Palasport, Eur Femi and Laurentina.  Each of these stations is serviced by Metro Line B.  Of the 4 stations, EUR Femi is the closest to the Palazzo dei Congressi.

                The closest Metro station to the Sheraton Roma is the the EUR Magliana, use Metro Line B to reach this station.


                Back Menu

                ECTS2016 Grants and Awards

                The European Calcified Tissue Society provides grants and awards to fund research and to assist new investigators with expenses related to their projects. For further information on individual grants and awards visit the ECTS website.

                The following awards will be made during the 2016 Congress.

                ECTS Excellence in Research Lecture

                This award is given to one of the invited speakers at the congress in recognition of their outstanding contributions to research in the field of bone and calcified tissues. The 2016 research lecture will be given by Tim Spector on Monday 16 May at 08:30 during the Symposium on Microbiome and musculoskeletal health.

                ECTS Mike Horton Basic/Translational Award

                Professor Mike Horton (1948-2010) was a hematologist-turned-scientist who made significant contributions in the bone field and beyond. He performed pioneering work in osteoclast biology which resulted, among other things, in the recognition of the alpha v beta 3 integrin as a therapeutic target for inhibiting bone resorption. His warm personality and wide-ranging interests inspired many young researchers.

                This award, by nomination only, is open to individuals who have made a significant basic or translational contribution to the field of bone and calcified tissue. The 2016 Mike Horton Award will be presented during the Awards 1 session on Sunday15 May at 14:15.

                ECTS Philippe Bordier Clinical Award

                Dr Philippe Bordier (1927-1977) contributed significantly to the bone field by developing bone histomorphometry, which he applied to the analysis of several bone diseases. His work and dynamism in science has been recognised in Europe and the United States.

                This award, by nomination only, is open to individuals who have made a significant clinical contribution to the field of bone and calcified tissue.The 2016 Philippe Bordier Award will be presented during the Awards 1 session on Sunday 15 May at 14:15.

                ECTS Iain T Boyle Award

                In memory of Professor Iain T Boyle (1935-2001) who contributed greatly to the field of mineral metabolism and his work on osteoporosis was known and acclaimed nationally and internationally. The award is open to young scientists who have made significant progress and contribution to the field of bone and calcified tissue. The 2016 Iain T Boyle Award will be presented during the Awards 1 session on Sunday 15 May at 14:15.

                ECTS/Amgen Bone Biology Fellowship
                Supported by Amgen

                This 3-year fellowship programme is open to any ECTS member, clinician or scientist working in the field of bone biology.
                The award will be used exclusively to support translational or clinical research in the area of bone disease, in particular projects which concern the RANK/RANKL/OPG pathway or Wnt pathway translated into clinical relevance of bone disease.
                The 2016 ECTS/Amgen Bone Biology Fellowship will be announced during the Awards 2 session on Monday 16 May at 14.15.

                ECTS Steven Boonen Clinical Research Award
                Supported by Amgen

                In memory of Professor Steven Boonen, who sadly passed away during the ECTS 50th Anniversary Congress in Lisbon on 20 May 2013. ECTS has introduced an annual Steven Boonen Clinical Research Award, supported by Amgen. The 2016 Steven Boonen Clinical Lecture will be given by Núria Guañabens on Saturday 14 May at 19.15.

                ECTS East-Meets-West Research Award - NEW!

                As part of the East-Meets-West Programme within the ECTS 2016 Annual Congress, the ECTS will present East-Meets-West Research Awards to researchers from China, Japan and Korea.  These awards are given to the top five ranking abstracts from each country.

                The 2016 East-Meets-West Research Awards will be presented during the Awards 2 session on Monday 16 May at 14.15 and during the East-Meets-West reception at 20.30.


                Back Menu

                ECTS2016 - Sponsors











                Nature Reviews



                Back Menu

                Please fill out this short questionnaire regarding your experience of ECTS 2016.

                ECTS 2016 Questionnaire

                Thank you in advance.



                Back Menu

                Please click the link below to view all iPosters 

                ECTS 2016 iPosters